Evidence map›Paper›PMID 26273518›Full record

ArticleBone research2014

Hypoxia-inducible factor-1α restricts the anabolic actions of parathyroid hormone.

Julie L Frey, David P Stonko, Marie-Claude Faugere, Ryan C Riddle

Open access · goldAbstract read
In one paragraph

Article in Bone research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. The Bioactive Compounds ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Anabolic actions of PTH in murine models: two decades of insights.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  17. Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Julie L FreyDepartment of Orthopaedic Surgery, Johns Hopkins University School of Medicine , Baltimore, MD, USA.
David P StonkoDepartment of Orthopaedic Surgery, Johns Hopkins University School of Medicine , Baltimore, MD, USA.
Marie-Claude FaugereDivision of Nephrology, Bone & Mineral Metabolism, University of Kentucky , Lexington, KY, USA.
Ryan C RiddleDepartment of Orthopaedic Surgery, Johns Hopkins University School of Medicine , Baltimore, MD, USA ; Veterans Administration Medical Center , Baltimore, MD, USA.
Johns Hopkins Medicine · USJohns Hopkins University · USUniversity of Kentucky · US

Funding

Hif-1 as an antagonist of load-induced bone formationIK2BX001284 · VA · BALTIMORE VA MEDICAL CENTER · PI RIDDLE, RYAN C · 2012 to 2014
–
BLRD VA IK2 BX001284
6 · The paper itself

Abstract

The hypoxia inducible factors (Hifs) are evolutionarily conserved transcriptional factors that control homeostatic responses to low oxygen. In developing bone, Hif-1 generated signals induce angiogenesis necessary for osteoblast specification, but in mature bone, loss of Hif-1 in osteoblasts resulted in a more rapid accumulation of bone. These findings suggested that Hif-1 exerts distinct developmental functions and acts as a negative regulator of bone formation. To investigate the function of Hif-1α in osteoanabolic signaling, we assessed the effect of Hif-1α loss-of-function on bone formation in response to intermittent parathyroid hormone (PTH). Mice lacking Hif-1α in osteoblasts and osteocytes form more bone in response to PTH, likely through a larger increase in osteoblast activity and increased sensitivity to the hormone. Consistent with this effect, exposure of primary mouse osteoblasts to PTH resulted in the rapid induction of Hif-1α protein levels via a post-transcriptional mechanism. The enhanced anabolic response appears to result from the removal of Hif-1α-mediated suppression of β-catenin transcriptional activity. Together, these data indicate that Hif-1α functions in the mature skeleton to restrict osteoanabolic signaling. The availability of pharmacological agents that reduce Hif-1α function suggests the value in further exploration of this pathway to optimize the therapeutic benefits of PTH.

Identifiers

PMID26273518
PMCPMC4472139
OpenAlexW937366788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.